RAD50 missense variants differentially affect the DNA damage response and mitotic progression
FEBS Letters · 2025
DOI: 10.1002/1873-3468.70175 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Letters, 2025. Verfasst von Hanna Redeker und 9 weiteren Autor:innen. Beteiligte Einrichtung: Gynaecology Research Unit, Hannover Medical School, Germany. Hauptthemen laut MEDLINE: Mitosis, Mutation, Missense, DNA Damage, DNA-Binding Proteins. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Claudia von Schilling Foundation.
Abstract (Originalsprache)
RAD50 is the central protein of the MRN complex and crucial in DNA double‐strand break repair. RAD50 deficiency causes a genomic instability disorder characterized by microcephaly and stunted growth. Using lentiviral constructs, we investigated whether cancer‐related RAD50 missense variants can complement the delayed damage response after exposure to the chemotherapeutic agent epirubicin and/or mitotic progression in RAD50‐deficient fibroblasts. Eight missense variants, all capable of forming an MRN complex, supported the DNA damage response and mitotic features to different extents, indicating these functions are separable. Three variants showed both an impaired epirubicin response and slowed cell division in the likely pathogenic range. Assessing RAD50 missense variants with distinct functional readouts may help to further elucidate their differential roles in immunodeficiency and cancer and could improve therapeutic strategies. Impact statement RAD50 has a strong impact on DNA repair and cancer therapy. Here, we analyse RAD50 missense variants at four functional levels. Some variants showed an impaired epirubicin response and mitotic progression in the pathological range, while for others these endpoints were separable. Functional heterogeneity of RAD50 variants could contribute to clinical variability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gynaecology Research Unit, Hannover Medical School, Germany.
- Institute of Experimental Hematology, Hannover Medical School, Germany.
- Institute of Human Genetics, Biocenter, University Würzburg, Germany.
ORCID-Profile: Thilo Dörk, Kristine Bousset
Förderung
- Claudia von Schilling Foundation
Zitieren
APA
Redeker, H., Kebel, S., Völkening, L., Vatselia, A., Weinhold, L., Asgedom, G., Schambach, A., Schindler, D., Dörk, T., & Bousset, K. (2025). RAD50 missense variants differentially affect the DNA damage response and mitotic progression. FEBS Letters. https://doi.org/10.1002/1873-3468.70175
Vancouver
Redeker H, Kebel S, Völkening L, Vatselia A, Weinhold L, Asgedom G, et al. RAD50 missense variants differentially affect the DNA damage response and mitotic progression. FEBS Letters. 2025. doi:10.1002/1873-3468.70175
BibTeX
@article{Redeker2025,
author = {Redeker, Hanna and Kebel, Swantje and Völkening, Lea and Vatselia, Anna and Weinhold, Louisa and Asgedom, Girmay and Schambach, Axel and Schindler, Detlev and Dörk, Thilo and Bousset, Kristine},
title = {RAD50 missense variants differentially affect the DNA damage response and mitotic progression},
journal = {FEBS Letters},
year = {2025},
doi = {10.1002/1873-3468.70175}
}
EUVIMED